{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:03:19Z","timestamp":1789383799961,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.molpha.2026.100140","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:44:43Z","timestamp":1782283483000},"page":"100140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["An integrated structural and functional profiling approach uncovers the mechanisms of pregnane X receptor binding and activation by pharmaceutical and environmental compounds"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2108-7287","authenticated-orcid":false,"given":"Quentin","family":"Derosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4413-9106","authenticated-orcid":false,"given":"Coralie","family":"Carivenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6790-9730","authenticated-orcid":false,"given":"Savannah","family":"Sirounian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhay","family":"Boulahtouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7436-7935","authenticated-orcid":false,"given":"Vanessa","family":"Delfosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-3622","authenticated-orcid":false,"given":"Patrick","family":"Balaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0643-7719","authenticated-orcid":false,"given":"William","family":"Bourguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.molpha.2026.100140_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.apsb.2016.06.011","article-title":"A brief history of the discovery of PXR and CAR as xenobiotic receptors","volume":"6","author":"Yan","year":"2016","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10.1016\/j.molpha.2026.100140_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/mol.117.110155","article-title":"PXR: more than just a master xenobiotic receptor","volume":"93","author":"Oladimeji","year":"2018","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.molpha.2026.100140_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/17425255.2018.1476488","article-title":"A current structural perspective on PXR and CAR in drug metabolism","volume":"14","author":"Buchman","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"10.1016\/j.molpha.2026.100140_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/dmd.122.000858","article-title":"Regulation of nuclear receptors PXR and CAR by small molecules and signal crosstalk: roles in drug metabolism and beyond","volume":"51","author":"Poudel","year":"2023","journal-title":"Drug Metab Dispos"},{"issue":"1-2","key":"10.1016\/j.molpha.2026.100140_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/17425255.2024.2309212","article-title":"Regulation of PXR in drug metabolism: chemical and structural perspectives","volume":"20","author":"Gee","year":"2024","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100140_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1172\/JCI21867","article-title":"Possible involvement of pregnane X receptor\u2013enhanced CYP24 expression in drug-induced osteomalacia","volume":"115","author":"Pascussi","year":"2005","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.molpha.2026.100140_bib7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1517\/17425255.2012.685237","article-title":"Role of CAR and PXR in xenobiotic sensing and metabolism","volume":"8","author":"Wang","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100140_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.08.030","article-title":"Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response","volume":"328","author":"Pondugula","year":"2013","journal-title":"Cancer Lett"},{"issue":"4","key":"10.1016\/j.molpha.2026.100140_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/03602532.2024.2366948","article-title":"Advances in drug resistance of osteosarcoma caused by pregnane X receptor","volume":"56","author":"Mao","year":"2024","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.molpha.2026.100140_bib10","first-page":"728","article-title":"Biology of PXR: role in drug-hormone interactions","volume":"13","author":"Wang","year":"2014","journal-title":"EXCLI J"},{"issue":"8","key":"10.1016\/j.molpha.2026.100140_bib11","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1172\/JCI41514","article-title":"Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice","volume":"121","author":"Wang","year":"2011","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.molpha.2026.100140_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000492","article-title":"Bisphenol A increases atherosclerosis in pregnane X receptor-humanized ApoE deficient mice","volume":"3","author":"Sui","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"1-2","key":"10.1016\/j.molpha.2026.100140_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11010-010-0583-6","article-title":"Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders","volume":"345","author":"Chaturvedi","year":"2010","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"10.1016\/j.molpha.2026.100140_bib14","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1210\/me.2005-0156","article-title":"The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges","volume":"19","author":"Orans","year":"2005","journal-title":"Mol Endocrinol"},{"issue":"9","key":"10.1016\/j.molpha.2026.100140_bib15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.bbagrm.2016.02.013","article-title":"Small-molecule modulators of PXR and CAR","volume":"1859","author":"Chai","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.molpha.2026.100140_bib16","first-page":"150","article-title":"Structural insights into the promiscuity and function of the human pregnane X receptor","volume":"5","author":"Watkins","year":"2002","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"5","key":"10.1016\/j.molpha.2026.100140_bib17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/me.2004-0346","article-title":"Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin","volume":"19","author":"Chrencik","year":"2005","journal-title":"Mol Endocrinol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100140_bib18","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020551118","article-title":"Mechanistic insights into the synergistic activation of the RXR-PXR heterodimer by endocrine disruptor mixtures","volume":"118","author":"Delfosse","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"48","key":"10.1016\/j.molpha.2026.100140_bib19","doi-asserted-by":"crossref","first-page":"11572","DOI":"10.1021\/bi901578n","article-title":"The structural basis of pregnane X receptor binding promiscuity","volume":"48","author":"Ngan","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.molpha.2026.100140_bib20","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1038\/ncomms9089","article-title":"Synergistic activation of human pregnane X receptor by binary cocktails of pharmaceutical and environmental compounds","volume":"6","author":"Delfosse","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.molpha.2026.100140_bib21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41467-017-00780-5","article-title":"SPA70 is a potent antagonist of human pregnane X receptor","volume":"8","author":"Lin","year":"2017","journal-title":"Nat Commun"},{"issue":"Pt 3","key":"10.1016\/j.molpha.2026.100140_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1107\/S2053230X2500069X","article-title":"A two-in-one expression construct for biophysical and structural studies of the human pregnane X receptor ligand-binding domain, a pharmaceutical and environmental target","volume":"81","author":"Carivenc","year":"2025","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"issue":"5","key":"10.1016\/j.molpha.2026.100140_bib23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1107\/S0909049510020005","article-title":"MxCuBE: a synchrotron beamline control environment customized for macromolecular crystallography experiments","volume":"17","author":"Gabadinho","year":"2010","journal-title":"J Synchrotron Radiat"},{"issue":"Pt 2","key":"10.1016\/j.molpha.2026.100140_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 2","key":"10.1016\/j.molpha.2026.100140_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1107\/S0907444909047374","article-title":"Integration, scaling, space-group assignment and post-refinement","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 1","key":"10.1016\/j.molpha.2026.100140_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1107\/S0907444905036693","article-title":"Scaling and assessment of data quality","volume":"62","author":"Evans","year":"2006","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 10","key":"10.1016\/j.molpha.2026.100140_bib27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr D Struct Biol"},{"issue":"Pt 4","key":"10.1016\/j.molpha.2026.100140_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"4","key":"10.1016\/j.molpha.2026.100140_bib29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2165\/00002512-199202040-00002","article-title":"Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders","volume":"2","author":"Wadworth","year":"1992","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.molpha.2026.100140_bib30","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/fcp.13039","article-title":"Nociceptive TRP channels function as molecular target for several antifungal drugs","volume":"38","author":"Okabe","year":"2024","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.molpha.2026.100140_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114368","article-title":"Characterization of human pregnane X receptor activators identified from a screening of the Tox21 compound library","volume":"184","author":"Lynch","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molpha.2026.100140_bib32","article-title":"The bioactivities of sclareol: a mini review","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.molpha.2026.100140_bib33","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/bbb\/zbad113","article-title":"Activity difference of three labdane diterpenoids on human constitutive androstane receptor","volume":"87","author":"Sekiguchi","year":"2023","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.molpha.2026.100140_bib34","article-title":"Review of the environmental occurrence, analytical techniques, degradation and toxicity of TBBPA and its derivatives","volume":"206","author":"Sunday","year":"2022","journal-title":"Environ Res"},{"issue":"9","key":"10.1016\/j.molpha.2026.100140_bib35","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1289\/ehp.1003328","article-title":"Peroxisome proliferator-activated receptor \u03b3 is a target for halogenated analogs of bisphenol A","volume":"119","author":"Riu","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.molpha.2026.100140_bib36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.chemosphere.2018.09.061","article-title":"Chlorinated and brominated bisphenol A derivatives: synthesis, characterization and determination in water samples","volume":"213","author":"Doumas","year":"2018","journal-title":"Chemosphere"},{"issue":"5","key":"10.1016\/j.molpha.2026.100140_bib37","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI3703","article-title":"The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions","volume":"102","author":"Lehmann","year":"1998","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.molpha.2026.100140_bib38","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1016\/j.bmc.2008.02.020","article-title":"N-1H-benzimidazol-5-ylbenzenesulfonamide derivatives as potent hPXR agonists","volume":"16","author":"Benod","year":"2008","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10.1016\/j.molpha.2026.100140_bib39","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3892\/ol.2013.1149","article-title":"Expression of the PXR gene in various types of cancer and drug resistance","volume":"5","author":"Qiao","year":"2013","journal-title":"Oncol Lett"},{"issue":"7","key":"10.1016\/j.molpha.2026.100140_bib40","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3390\/cells9071641","article-title":"The anti-cancer drug dabrafenib is a potent activator of the human pregnane X receptor","volume":"9","author":"Creusot","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.molpha.2026.100140_bib41","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1021\/acs.jmedchem.0c02245","article-title":"Designing out PXR activity on drug discovery projects: a review of structure-based methods, empirical and computational approaches","volume":"64","author":"Hall","year":"2021","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.molpha.2026.100140_bib42","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1021\/acs.jmedchem.1c01354","article-title":"Structure-based and knowledge-informed design of B-Raf inhibitors devoid of deleterious PXR binding","volume":"65","author":"Schneider","year":"2022","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.molpha.2026.100140_bib43","first-page":"1325","article-title":"Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes","volume":"29","author":"Drocourt","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.molpha.2026.100140_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.toxlet.2016.10.005","article-title":"Optical isomers of dihydropyridine calcium channel blockers display enantiospecific effects on the expression and enzyme activities of human xenobiotics-metabolizing cytochromes P450","volume":"262","author":"\u0160t\u011bp\u00e1nkov\u00e1","year":"2016","journal-title":"Toxicol Lett"},{"issue":"1","key":"10.1016\/j.molpha.2026.100140_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41392-025-02500-8","article-title":"The aryl hydrocarbon receptor: structure, signaling, physiology and pathology","volume":"11","author":"Coumoul","year":"2026","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.molpha.2026.100140_bib46","doi-asserted-by":"crossref","first-page":"7010","DOI":"10.1038\/s41467-022-34773-w","article-title":"Cryo-EM structure of the agonist-bound Hsp90-XAP2-AHR cytosolic complex","volume":"13","author":"Gruszczyk","year":"2022","journal-title":"Nat Commun"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:11:16Z","timestamp":1789380676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X26000404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0026895X26000404"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100140","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrated structural and functional profiling approach uncovers the mechanisms of pregnane X receptor binding and activation by pharmaceutical and environmental compounds","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100140"}}